Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Mal-PEG8-Val-Ala-PAB-SB-743921

Mal-PEG8-Val-Ala-PAB-SB-743921 (Compound D7) is a Drug-Linker Conjugates for ADC. Mal-PEG8-Val-Ala-PAB-SB-743921 consists of KSP inhibitor SB-743921 (HY-14661) and a linker. Mal-PEG8-Val-Ala-PAB-SB-743921 can be used for synthesis of ADCs[1].

Product Specifications

UNSPSC

12352203

Target

Drug-Linker Conjugates for ADC

Type

ADC Related

Related Pathways

Antibody-drug Conjugate/ADC Related

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/mal-peg8-val-ala-pab-sb-743921.html

Purity

99.28

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C1C2=CC=C(Cl)C=C2OC([C@@H](C(C)C)N(C(C3=CC=C(C)C=C3)=O)CCCNC(OCC4=CC=C(NC([C@H](C)NC([C@H](C(C)C)NC(CCOCCOCCOCCOCCOCCOCCOCCOCCNC(CCN5C(C=CC5=O)=O)=O)=O)=O)=O)C=C4)=O)=C1CC6=CC=CC=C6

Molecular Formula

C73H96ClN7O19

Molecular Weight

1411.03

References & Citations

[1]Li Y, et al. A novel antibody-KSP inhibitor conjugate improves KSP inhibitor efficacy in vitro and in vivo. Biomaterials. 2023 Jul 28;301:122258.

Shipping Conditions

Blue Ice

Storage Conditions

-20°C (Powder, protect from light, stored under nitrogen)

Scientific Category

ADC Related

Clinical Information

No Development Reported

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

SKA-31
MBS3842092-01 10 mg

SKA-31

Ask
View Details
SKA-31
MBS3842092-02 25 mg

SKA-31

Ask
View Details
SKA-31
MBS3842092-03 50 mg

SKA-31

Ask
View Details
SKA-31
MBS3842092-04 100 mg

SKA-31

Ask
View Details
SKA-31
MBS3842092-05 5x 100 mg

SKA-31

Ask
View Details
RPL5P30 3'UTR Lenti-reporter-Luc Vector
41741081 1.0 µg

RPL5P30 3'UTR Lenti-reporter-Luc Vector

Ask
View Details